CVS Health Stock Forecast

Stock Price Forecast

The 18 analysts that cover CVS Health stock have a consensus rating of "Strong Buy" and an average price target of $94.33, which forecasts a 20.92% increase in the stock price over the next year. The lowest target is $80 and the highest is $102.

Price Target: $94.33 (+20.92%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$80	$94.33	$95	$102
Change	+2.55%	+20.92%	+21.78%	+30.75%

Analyst Ratings

The average analyst rating for CVS Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	5	6	7	6	8	7
Buy	11	11	11	11	10	10
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	18	19	18	19	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Steve Silver Argus Research	Argus Research	Strong Buy Maintains $91 → $90	Strong Buy	Maintains	$91 → $90	+15.37%	Jan 28, 2026
Michael Cherny B of A Securities	B of A Securities	Strong Buy Maintains $100 → $95	Strong Buy	Maintains	$100 → $95	+21.78%	Jan 27, 2026
Lisa Gill JP Morgan	JP Morgan	Buy Maintains $93 → $101	Buy	Maintains	$93 → $101	+29.47%	Dec 17, 2025
Lance Wilkes Bernstein	Bernstein	Hold Maintains $86 → $87	Hold	Maintains	$86 → $87	+11.52%	Dec 12, 2025
David Macdonald Truist Securities	Truist Securities	Strong Buy Maintains $95 → $98	Strong Buy	Maintains	$95 → $98	+25.62%	Dec 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

409.95B

from 399.83B

2.53%

from 399.83B

Revenue Next Year

429.57B

from 409.95B

4.78%

from 409.95B

EPS This Year

7.24

from 1.39

420.97%

from 1.39

EPS Next Year

8.31

from 7.24

14.76%

from 7.24

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	290.91B	321.63B	356.62B	370.66B	399.83B	409.95B	429.57B
Revenue Growth	8.59%	10.56%	10.88%	3.94%	7.87%	2.53%	4.78%
EPS	6.02	3.26	6.47	3.66	1.39	7.24	8.31
EPS Growth	10.19%	-45.85%	98.47%	-43.43%	-62.02%	420.97%	14.76%
Forward PE	-	-	-	-	-	10.77	9.39
No. Analysts	-	-	-	-	-	29	26

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	446.3B	469.4B
Avg	410.0B	429.6B
Low	388.2B	400.2B

Revenue Growth

Revenue Growth	2026	2027
High	11.6%	14.5%
Avg	2.5%	4.8%
Low	-2.9%	-2.4%

EPS Forecast

EPS	2026	2027
High	7.88	9.45
Avg	7.24	8.31
Low	6.77	7.55

EPS Growth

EPS Growth	2026	2027
High	466.5%	30.5%
Avg	421.0%	14.8%
Low	387.2%	4.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.